Vicarious Surgical (Vicarious Surgical) ROCE % : -63.92% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Vicarious Surgical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vicarious Surgical's annualized ROCE % for the quarter that ended in Mar. 2024 was -63.92%.

Vicarious Surgical ROCE % Historical Data

The historical data trend for Vicarious Surgical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicarious Surgical ROCE % Chart

Vicarious Surgical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

-75.83

-36.50

3.49

-58.12

Vicarious Surgical Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial										-87.43	-58.01	-56.77	-44.21	-63.92

Vicarious Surgical ROCE % Calculation

Vicarious Surgical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-71.046	/	( ( (140.291 - 8.393)	+	(119.864 - 7.28) )	/ 2 )
	=	-71.046	/	( (131.898	+	112.584)	/ 2 )
	=	-71.046	/	122.241
	=	-58.12 %

Vicarious Surgical's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-68.004	/	( ( (119.864 - 7.28)	+	(105.286 - 5.076) )	/ 2 )
	=	-68.004	/	( ( 112.584	+	100.21 )	/ 2 )
	=	-68.004	/	106.397
	=	-63.92 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Vicarious Surgical (NYSE:RBOT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vicarious Surgical ROCE % Related Terms

Thank you for viewing the detailed overview of Vicarious Surgical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicarious Surgical (Vicarious Surgical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicarious Surgical Inc (NYSE:RBOT) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

78 Fourth Avenue, Waltham, MA, USA, 02451

Website

https://www.vicarioussurgical.com

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

Executives

William John Kelly	officer: CFO and Treasurer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Adam David Sachs	director, 10 percent owner, officer: President and CEO	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Sammy Khalifa	director, 10 percent owner, officer: Chief Technology Officer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
June Morris	officer: CLO, General Counsel and Sec	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
John Mazzola	officer: Chief Operating Officer	TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810
Khosla Ventures Opportunity Associates Ii, Llc	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures V, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures Opportunity Ii, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
David D Ho	director	UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000
Philip Liang	director	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Brendel Victoria Carr	director	C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451
Beverly A Huss	director	C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
E15 Fund Ii, Lp	other: Sole Shareholder	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Shrikant Patnaik	other: Principal	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Ric Fulop	director	C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803